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Introduction
Medullary thyroid cancer (MTC) is derived from the C-cells or
the parafollicular cells of the thyroid and currently accounts
for 5–8% of all thyroid cancers.1,2 Histologically, it shows
unusual features such as trabeculae, papillae, follicles, oxy-
philic small cells and, sometimes, anaplastic features. The
presence of amyloid deposits and positive immunohisto-
chemistry usually confirms the diagnosis of MTC.
Papillary thyroid cancer is the most common thyroid cancer,
accounting for 75–80% of all thyroid cancers.1,2 It arises from
the thyroid follicular cells and is characterized by the presence
of papillae and specific cellular changes such as pseudonuclear
inclusions, nuclear grooves, nuclear clearing and moulding of
nuclei.
Simultaneous occurrence of medullary and papillary thy-
roid carcinomas in the same gland is rare. In fact, there are only
13 reports describing a total of 17 cases of simultaneous
occurrence of medullary and papillary thyroid carcinoma in
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the literature.3–15 Although the two cancers have different cells
of origin, they share some genetic predisposition. In this pa-
per, we describe a patient with MTC and lymph node metas-
tasis on one side and papillary thyroid cancer on the other side,
and raise the question of whether the finding of another
thyroid cancer on the other side was coincidental or from a
possible activation of a common tumorigenic pathway for
both follicular and parafollicular cells of the thyroid.
Case report
A 55-year-old woman was diagnosed with MTC after left hemi-
thyroidectomy for goitre. Five weeks later, she presented to
Jordan University Hospital with cervical neck swelling on the
left side. On admission, she was found to have a left cervical
mass measuring 5 = 3 cm, her blood pressure was normal, and
there was no apparent family history of thyroid cancer or any
disease of the parathyroid, adrenal, pituitary or pancreas. Her
serum levels of calcium, thyroid stimulating hormone and free
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It was connected to a 5 = 3 cm mass representing the left deep
group of cervical lymph nodes. Microscopic examination of all
masses on the left side showed a tumour formed of proliferat-
ing sheets of cells with oval hyperchromatic nuclei and promi-
nent nucleoli with scant cytoplasm and a background of a
pink homogeneous material that stained positive with Congo
red (Figure 3). Immunohistochemically, the tumour cells were
reactive for calcitonin and carcinoembryonic antigen (CEA)
(Figure 4) but not for thyroglobulin. The patient recovered
uneventfully and was discharged on the fifth postoperative
day.
Discussion
Papillary thyroid carcinoma is the most common malignant
tumour of the thyroid. It is a well-differentiated neoplasm
characterized by papillary architecture and distinctive cyto-
logical features. Papillary carcinoma tends to metastasize
thyroxine were normal. The baseline serum calcitonin level
was 767 pg/mL (normal, < 100 pg/mL).
Computed tomography revealed the presence of the thy-
roid remnant and cervical lymphadenopathy on the left side.
Completion thyroidectomy, central neck dissection and left
modified neck dissection were performed.
Grossly, the right thyroidectomy specimen measured 4 = 3
cm at the greatest dimensions. Cut sectioning showed a whit-
ish nodule measuring 2 = 1 cm. Microscopically, the sections
of the right lobe showed a papillary thyroid carcinoma involv-
ing the whole nodule. The tumour comprised well-formed
papillae showing fibrovascular cores lined by oval to round
nuclei with clearing, grooving and pseudoinclusions consist-
ent with papillary thyroid carcinoma (Figure 1). Immunohis-
tochemical staining of these cells was strongly positive for
thyroglobulin (Figure 2) but not for calcitonin.
Remnants of the left lobe, measuring 2 = 1.5 cm at the
greatest dimensions, contained multiple irregular whitish areas.
Figure 1. Papillary thyroid carcinoma showing papillae, clearing of
nuclei and pseudoinclusions (haematoxylin & eosin).
Figure 4. Positive calcitonin immunostaining in the medullary
carcinoma (10 = 20).
Figure 3. Medullary thyroid carcinoma showing proliferating tu-
mour cells irregularly arranged on amyloid-rich stroma (haematoxylin
& eosin).
Figure 2. Immunohistochemical stain for thyroglobulin in papillary
carcinoma showing positive epithelial cells (10 = 20).
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via the lymphatic channels, and its prognosis is generally
favourable. Medullary carcinomas, which are of different
embryological origin, differ from papillary thyroid carcinoma
in their growth pattern and their greater propensity for
locoregional invasion. The prognosis of MTC is generally
worse than that of papillary thyroid cancer.16
Papillary thyroid cancers arise from the follicular cells of
the thyroid, which are derived from a median endodermal
anlage from the tongue. Papillary thyroid cells produce
thyroglobulins and thyroid hormones. MTCs arise from the
parafollicular cells of the ultimobranchial body derived from
the neural crest. Medullary carcinomas produce calcitonin
and other hormonal peptides and are considered part of the
amine precursor uptake and decarboxylation system.17
The concurrence of MTC and papillary thyroid carcinoma
within the same thyroid has been sporadically reported. Only
17 cases of mixed and simultaneous thyroid tumours have
been reported in the literature.3–15 Most of these reports de-
scribe mixed tumours with morphological and immunohisto-
chemical traits of both carcinomas.4–6 In one report, the diag-
nosis was made from fine-needle aspiration cytology of two
nodules, one on the right side that was positive for calcitonin
and CEA and the other on the left that was consistent with
papillary thyroid carcinoma. In another report by Mazziotti et
al, simultaneous medullary and papillary thyroid carcinoma
was found in a patient with Graves’ disease.13 To the best of our
knowledge, this is the first reported case from Jordan and
possibly the second case from the region (personal communi-
cation with colleagues in Saudi Arabia).
Although the thyroid gland is not considered part of the
diffuse endocrine system, it is worth noting that the concur-
rence of both tumours in the same gland may suggest that
these tumours have a common stem cell origin. The theory of
a common stem cell that gives rise to both parafollicular C-
cells and follicular epithelial cells was proposed by Ljunberg in
1983.18 According to this theory, the ultimobranchial body is
the most likely source of this putative common stem cell
because the nests of these cells in the thyroid gland show
immunoreactivity for both thyroglobulin and calcitonin, sug-
gesting that the ultimobranchial body may have contributed
to both the parafollicular cells and the follicular epithelial
cells.
The second hypothesis regarding the tumorigenesis of
thyroid cancers showing features of both medullary and pap-
illary carcinomas is the possibility of a common tumorigenic
stimulus triggering neoplastic transformation for both cell
lines, leading to medullary and papillary thyroid carcinoma.
Both tumours occur in familial forms, especially MTC, of
which 10% are familial. In our case, there was no family history
to suggest the familial variety of MTC.
Familial MTC is associated with a positive RET oncogene
mutation. Specific mutations of RET are responsible for the
inherited cancer syndromes MEN2A, MEN2B and familial
MTC.19 Rearrangement of the RET proto-oncogene represents
one of the most common genetic alterations found in papil-
lary thyroid carcinoma. Unfortunately, we could not perform
either a RET oncogene or a RET/papillary thyroid carcinoma
analysis in our patient because of technical problems.
The third explanation for this rare presentation is that it is
just a coincidental finding since the incidence of papillary
thyroid carcinoma is high and there is some evidence to sug-
gest that these two cancers have different patterns of RET
proto-oncogene mutation, loss of heterozygosity and X-
chromosomal inactivation according to Volante et al.20
In conclusion, simultaneous occurrence of MTC and pap-
illary thyroid carcinoma in the same thyroid gland is extremely
rare. Controversies still exist regarding whether this is just a
coincidence or related to a common stem cell origin or possi-
ble common triggering genetic factors.
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